Market Tracker

01/18 5:16pm ET

Geron Corp (NASDAQ:GERN)

2.06
Delayed Data
As of 4:00pm ET
 +0.02 / +0.98%
Today’s Change
1.81
Today|||52-Week Range
3.43
-0.48%
Year-to-Date
3 Reasons Geron Corporation Plunged 57% in 2016
Jan 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.04
Today’s open2.05
Day’s range2.00 - 2.06
Volume1,512,082
Average volume (3 months)1,718,700
Market cap$324.7M
Dividend yield--
Data as of 4:00pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.28

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...-0.23-2.03%
PTGXProtagonist Therapeu...-0.05-0.26%
XBITXBiotech Inc+0.22+2.13%
ADAPAdaptimmune Therapeu...0.000.00%
Data as of 4:00pm ET, 01/18/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts